We are live on
!
Find out more
KITE
Kite Pharma, Inc.
KITE
KITE
Delisted
KITE was delisted on the 2nd of October, 2017.
0 hedge funds and large institutions have $0 invested in Kite Pharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 241 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 244 → 0 (-244)
100% less funds holding in top 10
Funds holding in top 10: 23 → 0 (-23)
100% less capital invested
Capital invested by funds: $8.87B → $0 (-$8.87B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 241
Holders
–
Holders Change
-244
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
241
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
CI
Cowen Inc
New York
|
-$755M |
| 2 |
BlackRock
New York
|
-$744M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$736M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$483M |
| 5 |
WCM
Wildcat Capital Management
New York
|
-$433M |
